Pulmonary and intestinal tuberculosis in a kidney transplant recipient
https://doi.org/10.23873/2074-0506-2019-11-2-141-149
Abstract
Introduction. Tuberculosis is one of the most common infections in the general population, as well as among the recipients of solid organs. In kidney transplant recipients, the diagnosis of tuberculosis is often extremely difficult to make because of unclear clinical and radiological symptoms, and a highly frequent atypical (extrapulmonary) localization. The tuberculosis treatment in patients on drug immunosuppression is a significant problem.
Clinical case. At five years after renal transplantation, the patient noted the onset of fever up to 38 degrees C. It was suspicious of respiratory infection. Chest X-ray, computed tomography, and ultrasound examination of the graft revealed no pathology. Antibacterial and antiviral therapy brought stable improvement. A repeated computer tomography demonstrated an enhanced pulmonary pattern in S6 of the left lung with visualization of small grouped lesions located peribronchially, the terminal ileitis in the abdominal cavity: (an intensive contrast accumulation in the mucosa of the affected part of the small intestine, the mesentery hypervascularity at this level). A colonoenteroscopy with a ileum intestine biopsy was performed; the findings were highly consistent with a tuberculous process. A targeted treatment of tuberculosis was carried out, which had a marked positive trend.
Conclusion. Thus, the diagnosis of tuberculosis in kidney transplant recipients is complex; the clinical signs and instrumental test results are often ambiguous, which greatly complicates the timely diagnosis. An integrated approach with the use of modern diagnostic methods is required.
About the Authors
R. O. KantariyaRussian Federation
Cand. Med. Sci., Associate Professor of Transplantology, Nephrology and Artificial Organs Department, Faculty of Medical Postgraduate Education,
61/2 Shchepkin St., Moscow 129110
A. V. Vatazin
Russian Federation
Prof., Dr. Med. Sci, Head of the Surgical Department of Kidney Transplantation, Head of Transplantology, Nephrology and Artificial Organs Department, Faculty of Medical Postgraduate Education,
61/2 Shchepkin St., Moscow 129110
A. B. Zul’karnayev
Russian Federation
Dr. Med. Sci., Chief Researcher of the Surgical Department of Kidney Tansplantation,
61/2 Shchepkin St., Moscow 129110
V. A. Stepanov
Russian Federation
Cand. Med. Sci., Senior Researcher of the Surgical Department of Kidney Transplantation,
61/2 Shchepkin St., Moscow 129110
References
1. Sulis G., Roggi A., Matteelli A., Raviglione M.C. Tuberculosis: epidemiology and control. Mediterr J Hematol Infect Dis. 2014;6(1):e2014070. PMID:25408856 DOI:10.4084/MJHID.2014.070
2. Haley C.A. Treatment of Latent Tuberculosis Infection. Microbiol Spectr. 2017;5(2). PMID:28409555 DOI:10.1128/microbiolspec.TNMI7-0039-2016
3. Nagavci B.L., de Gelder R., Martikainen P., et al. Inequalities in tuberculosis mortality: long-term trends in 11 European countries. Int J Tuberc Lung Dis. 2016;20(5):574–581. PMID:27084808 DOI:10.5588/ijtld.15.0658
4. Boubaker K., Gargah T., Abderrahim E., et al. Mycobacterium tuberculosis infection following kidney transplantation. Biomed Res Int. 2013;2013:347103. PMID:24222903 DOI:10.1155/2013/347103
5. Muñoz P., Rodríguez C., Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis. 2005;40(4):581–587. PMID:15712081 DOI:10.1086/427692
6. Coll E., Torre-Cisneros J., Calvo R., et al. Incidence of tuberculosis in deceasedorgan donors and transmission risk to recipients in Spain. Transplantation. 2013;96(2):205–210. PMID:23774810 DOI:10.1097/TP.0b013e3182977adf.
7. Prokopenko E.I., Shcherbakova E.O., Vatazin A.V., et al. Lung infections in renal transplant recipients Data of single-center study. Nephrology and dialysis. 2011;13(2):101–111. (In Russian).
8. Krstich M., Vetchinnikova O.N., Astakhov P.V., Zul’karnayev A.B. Urosepsis in patients with chronic kidney disease: risk factors, clinical features and treatment strategy. Almanac of Clinical Medicine. 2012;26:28–34. (In Russian).
9. Dorman S.E., Chaisson R.E. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat Med. 2007;13(3):295–298. PMID:17342143 DOI:10.1038/nm0307- 295
10. Falzon D., Jaramillo E., Schünemann H.J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38(3):516–528. PMID:21828024 DOI:10.1183/09031936.00073611
11. Ulubay G., Kupeli E., Duvenci Birben O., et al. A 10-year experience of tuberculosis in solid organ transplant recipients. Exp Clin Transplant. 2015;13(Suppl 1):214–218. PMID:25894157
12. Vatazin A.V., Gautier S.V., Moysyuk Ya.G., et al. Diagnosis, treatment and prevention of infectious complications in patients with a transplanted kidney: clinical guidelines. Moscow, 2014. Available at: http://nonr.ru/?page_id=3178. (In Russian).
Review
For citations:
Kantariya R.O., Vatazin A.V., Zul’karnayev A.B., Stepanov V.A. Pulmonary and intestinal tuberculosis in a kidney transplant recipient. Transplantologiya. The Russian Journal of Transplantation. 2019;11(2):141-149. https://doi.org/10.23873/2074-0506-2019-11-2-141-149